FIELD: organic chemistry, chemical technology, medicine, pharmacy.
SUBSTANCE: invention relates to compounds of the formula (I):
wherein NRR1 is joined at position 5 or 6 of furopyridine ring; R represents hydrogen atom, (C1-C4)-alkyl or COR2; R1 represents (CH2)nAr, CH2CH=CHAr or CH2C≡CAr; n = 0-3; A represents nitrogen atom or NO; Ar represents 5- or 6-membered aromatic or heteroaromatic ring that comprises 0-4 nitrogen atoms, 0-1 oxygen atom and 0-1 sulfur atom; or 8-, 9- or 10-membered condensed aromatic or heteroaromatic cyclic system comprising 0-4 nitrogen atoms, 0-1 oxygen atom and 0-1 sulfur atom and any of that can be, optionally, substituted with 1-2 substituents taken independently among halogen atom, trifluoromethyl or (C1-C4)-alkyl; R2 represents hydrogen atom, (C1-C4)-alkyl, (C1-C4)-alkoxy-group or phenyl ring optionally substituted with 1-3 following substituents : halogen atom, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, OH, (OC1-C4)-alkyl, CO2R5, -CN, -NO2, -NR3R4 or -CF3; R3, R4, R5 can mean hydrogen atom, (C1-C4)-alkyl or phenyl ring optionally substituted with 1-3 following substituents: halogen atom, (C1-C4)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, OH, (OC1-C4)-alkyl, -CN, -NO2 or -CF3; to their enantiomers and pharmaceutically acceptable salts. Prepared compounds elicit agonistic activity with regards to nicotine receptors of acetylcholine and can be used for treatment or prophylaxis of psychotic disorders or disorders of mental capacity.
EFFECT: improved preparing method, valuable medicinal and pharmacological properties of compounds.
27 cl, 1 tbl, 36 ex
Title |
Year |
Author |
Number |
SPIROAZOBICYCLIC HETEROCYCLIC COMPOUNDS, METHODS OF THEIR SYNTHESIS, INTERMEDIATE COMPOUNDS AND PHARMACEUTICAL COMPOSITION |
1998 |
- Fillips Ehjfion
- Mehk Robert
- Mehjkor Dzhon
- Semas Sajmon
|
RU2202553C2 |
NICOTINIC RECEPTOR LIGANDS |
2007 |
- Chang Gui-Fang
- Khol'Mkvist Kristofer
- Fillips Ehjfion
- Pajzer Timoti
- Simpson Tomas
- Urbanek Rebekka
- Vuds Dzhejms
- Ksiong Gui
|
RU2441007C2 |
3-(HETEROARYLOXY)-2-ALKYL-1-AZABICYCLOALKYL DERIVATIVES AS LIGANDS OF ALPHA-7-nAChR (NICOTINIC ACETYLCHOLINE RECEPTORS), MEANT FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES |
2005 |
- Fojerbakh Dominik
- Roj Bernar Ljus'En
- Khurt Konstantse
- Frederiksen Mattias
|
RU2402551C2 |
DERIVATIVES OF QUINUCLIDINEAMIDE, METHOD FOR THEIR PREPARING AND THEIR USING, PHARMACEUTICAL COMPOSITION, COMBINED PRODUCT AND METHOD FOR INHIBITION OF MUSCARINIC RECEPTORS |
2003 |
|
RU2314306C2 |
NOVEL ESTERS OF QUATERNISED QUINUCLIDINE |
2005 |
- Fernandes-Forner Marija-Dolors
- Prat-Kinones Marija
- Buil'-Al'Bero Marija-Antonija
|
RU2382041C2 |
QUINUCLIDINE CARBAMATES, METHODS FOR THEIR PREPARING AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
2001 |
- Buil Al'Bero Marija Antonija
- Fernandes Forner Marija Dolors
- Prat Kin'Ones Marija
|
RU2296762C2 |
PYRIDOPYRIMIDINE COMPOUND, METHOD FOR PRODUCTION, PHARMACEUTICAL COMPOSITION AND APPLICATION OF INDICATED COMPOUNDS |
2014 |
- Shen, Jingkang
- Yu, Ke
- Meng, Tao
- Ma, Lanping
- Zask, Arie
- Meng, Lanfang
- Wang, Xin
- Chen, Yiyi
|
RU2662713C2 |
COMPOUNDS, MEDICINAL AGENTS, TREATMENT METHODS, METHOD FOR PREPARING COMPOUNDS |
2001 |
- Fillips Ehjfion
- Shmizing Richard
|
RU2263114C2 |
QUINUCLIDINE DERIVATIVES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION, METHOD FOR TREATMENT AND INTERMEDIATE SUBSTANCES |
2000 |
- Fernandes Forner Dolors
- Prat Kin'Ones Marija
- Buil Al'Bero Marija Antonija
|
RU2264401C2 |
2-(AZAINDOL-2-YL)BENZIMIDAZOLE DERIVATIVES AS PAD4 INHIBITORS |
2012 |
- Atkinson Stephen John
- Barker Michael David
- Campbell Matthew
- Diallo Hawa
- Douault Clement
- Garton Neil Stuart
- Liddle John
- Sheppard Robert John
- Walker Ann Louise
- Wellaway Christopher
- Wilson David Matthew
|
RU2611010C2 |